LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Kerry Ose <[log in to unmask]>
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Wed, 5 Apr 2006 11:27:05 -0400
Content-Type:
text/plain
Parts/Attachments:
text/plain (26 lines)
Hi, all -- I seem to remember that the suspicion about the FDA crack down on
domperidone might be related to industry pressure from the company that
makes and sells Reglan.  Domperidone is made and marketed by a European
pharmaceutical company and Reglan is a US product, I believe.  While I think
the outlawing of domperidone is the US is suspect, I don't think it has to
do with the fact that it potentially leads to a reduction in formula sales,
but that it cut into the market for Reglan.  

For those who might not know, Reglan can also be used to increase milk
production, but many health and lactation professionals do not like to use
it because of apparent untoward side effects.

Kerry Ose

             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(R)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html

ATOM RSS1 RSS2